For over 25 years, Medtronic has been a global leader in deep brain stimulation (DBS) device design and development. And today, more than 175,000 Medtronic DBS devices* have been implanted to treat Parkinson’s disease, epilepsy, essential tremor, dystonia, and obsessive-compulsive disorder (OCD).
View clinical research, understand patient selection, and discover why DBS is an important addition to the treatment continuum for the following indications.
Number of unique patients implanted (i.e “new patients”)
Salanova V, Witt T, Worth R et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology 2015;84(10):1017-1025.